Your browser doesn't support javascript.
loading
Determinants of de novo B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections.
Quirk, Grace E; Schoenle, Marta V; Peyton, Kameron L; Uhrlaub, Jennifer L; Lau, Branden; Burgess, Jefferey L; Ellingson, Katherine; Beitel, Shawn; Romine, James; Lutrick, Karen; Fowlkes, Ashley; Britton, Amadea; Tyner, Harmony L; Caban-Martinez, Alberto J; Naleway, Allison; Gaglani, Manjusha; Yoon, Sarang; Edwards, Laura; Olsho, Lauren; Dake, Michael; LaFleur, Bonnie J; Nikolich, Janko Z; Sprissler, Ryan; Worobey, Michael; Bhattacharya, Deepta.
Affiliation
  • Quirk GE; Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ, USA.
  • Schoenle MV; Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA.
  • Peyton KL; Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA.
  • Uhrlaub JL; Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ, USA.
  • Lau B; University of Arizona Genomics Core and the Arizona Research Labs, University of Arizona Genetics Core, University of Arizona, Tucson, AZ, USA.
  • Burgess JL; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
  • Ellingson K; Department of Epidemiology and Biostatistics, Zuckerman College of Public Health, University of Arizona, Tucson.
  • Beitel S; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
  • Romine J; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA.
  • Lutrick K; College of Medicine-Tucson, University of Arizona, Tucson, Arizona, USA.
  • Fowlkes A; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
  • Britton A; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
  • Tyner HL; St. Luke's Regional Health Care System, Duluth, Minnesota, USA.
  • Caban-Martinez AJ; University of Miami, Leonard M. Miller School of Medicine, Miami, FL, USA.
  • Naleway A; Kaiser Permanente Northwest Center for Health Research, Portland, Oregon, USA.
  • Gaglani M; Baylor Scott & White Health and Texas A&M University College of Medicine, Temple, Texas, USA.
  • Yoon S; Rocky Mountain Center for Occupational and Environmental Health, Department of Family and Preventive Medicine, University of Utah Health, Salt Lake City, Utah, USA.
  • Edwards L; Abt Associates, Rockville, Maryland, USA.
  • Olsho L; Abt Associates, Rockville, Maryland, USA.
  • Dake M; Office of the Senior Vice-President for Health Sciences, University of Arizona, Tucson, AZ, USA.
  • LaFleur BJ; BIO5 Institute, University of Arizona, Tucson, AZ, USA.
  • Nikolich JZ; BIO5 Institute, University of Arizona, Tucson, AZ, USA.
  • Sprissler R; University of Arizona Center on Aging, University of Arizona College of Medicine, Tucson, AZ, USA.
  • Worobey M; University of Arizona Genomics Core and the Arizona Research Labs, University of Arizona Genetics Core, University of Arizona, Tucson, AZ, USA.
  • Bhattacharya D; Department of Ecology and Evolutionary Biology, University of Arizona, Tucson, AZ, USA.
medRxiv ; 2023 Sep 14.
Article in En | MEDLINE | ID: mdl-37745498
ABSTRACT
Vaccine-induced immunity may impact subsequent de novo responses to drifted epitopes in SARS-CoV-2 variants, but this has been difficult to quantify due to the challenges in recruiting unvaccinated control groups whose first exposure to SARS-CoV-2 is a primary infection. Through local, statewide, and national SARS-CoV-2 testing programs, we were able to recruit cohorts of individuals who had recovered from either primary or post-vaccination infections by either the Delta or Omicron BA.1 variants. Regardless of variant, we observed greater Spike-specific and neutralizing antibody responses in post-vaccination infections than in those who were infected without prior vaccination. Through analysis of variant-specific memory B cells as markers of de novo responses, we observed that Delta and Omicron BA.1 infections led to a marked shift in immunodominance in which some drifted epitopes elicited minimal responses, even in primary infections. Prior immunity through vaccination had a small negative impact on these de novo responses, but this did not correlate with cross-reactive memory B cells, arguing against competitive inhibition of naïve B cells. We conclude that dampened de novo B cell responses against drifted epitopes are mostly a function of altered immunodominance hierarchies that are apparent even in primary infections, with a more modest contribution from pre-existing immunity, perhaps due to accelerated antigen clearance.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: MedRxiv Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: MedRxiv Year: 2023 Type: Article Affiliation country: United States